top of page
Search

New Publication

  • christophkleber
  • Jun 4, 2025
  • 1 min read
Our recent publication explores the possiblity for early liver disease detection - by analyzing compounds in human breath using limonene as promising biomarker.
Our recent publication explores the possiblity for early liver disease detection - by analyzing compounds in human breath using limonene as promising biomarker.


New publication by Prof. Priv.-Doz. DI Dr. Christoph Kleber, Dr. Erich Kny and Wiktor Luczak, MSc, titled “Limonene Detection in the Exhaled Human Breath Providing an Early Diagnosis Method of Liver Diseases”.


The literature review summarizes possible methods for the detection of limonene in the gas phase at low to very low concentrations. Recently, limonene has been recognized as an effective biomarker for human metabolic disorders, including liver diseases and certain cancers. Developing new limonene sensors could potentially allow to screen for liver dysfunction using non-invasive breath tests. This would not only improve early diagnosis and survival rates but also help reduce healthcare costs significantly.


 
 
 

Comments


bottom of page